Neurocognitive Disorders

Latest

Mortality Rates in Parkinson Disease Psychosis With Pimavanserin, Quetiapine

Mortality Rates in Parkinson Disease Psychosis With Pimavanserin, Quetiapine

In patients with Parkinson disease psychosis, treatment with pimavanserin has a lower risk for mortality compared with quetiapine or combination therapy.

Anxiety Increases Freezing of Gait Severity in Individuals With Parkinson Disease

Anxiety Increases Freezing of Gait Severity in Individuals With Parkinson Disease

The authors suggest that anxiety should be routinely evaluated in patients with Parkinson disease who experience freezing of gait.

Feeling Young May Be Reflected in Brain Structure

Feeling Young May Be Reflected in Brain Structure

People who feel younger than their age show fewer signs of brain aging than those who feel their age or older than their age.

FDA Approves New Nuplazid Formulation, Dosage Strength

FDA Approves New Nuplazid Formulation, Dosage Strength

Nuplazid, a non-dopaminergic, selective serotonin inverse agonist, targets 5-HT2A receptors that are thought to be involved in Parkinson disease psychosis.

Examining the Content, Frequency of Auditory Hallucinations in Dementia

Examining the Content, Frequency of Auditory Hallucinations in Dementia

These results highlight the risk for auditory hallucinations in certain subsets of patients with dementia with Lewy bodies and may be useful for clinicians in developing targeted treatment options.

Worse Cognitive Outcomes Associated With CMV Antibodies Following ART for HIV

Worse Cognitive Outcomes Associated With CMV Antibodies Following ART for HIV

Investigators sought to determine the association between antiretroviral therapy and cytomegalovirus infection in individuals with HIV, as well as the potential impact of both on neurocognitive performance.

Low Serum Sodium Linked to Cognitive Decline in Older Men

Low Serum Sodium Linked to Cognitive Decline in Older Men

126 to 140 mmol/L was linked to increased odds of prevalent cognitive impairment and decline in older men.

Intervention Improves Quality of Life, Agitation in Nursing Home Patients With Dementia

Intervention Improves Quality of Life, Agitation in Nursing Home Patients With Dementia

Patients randomly assigned to the intervention experienced a statistically significant improvement in quality of life, agitation, and overall neuropsychiatric symptoms.

Goal-Oriented Cognitive Rehabilitation vs As-Usual Care Outcomes in Parkinson Disease

Goal-Oriented Cognitive Rehabilitation vs As-Usual Care Outcomes in Parkinson Disease

Cognitive rehabilitation may be an effective therapy for Parkinson-associated dementias.

AAN Issues New Guidelines for Treatment of Mild Cognitive Impairment

AAN Issues New Guidelines for Treatment of Mild Cognitive Impairment

The AAN has issued new recommended guidelines for treating mild cognitive impairment.

Sign Up for Free e-newsletters